339 related articles for article (PubMed ID: 23524887)
1. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.
Song P; Feng X; Zhang K; Song T; Ma K; Kokudo N; Dong J; Yao L; Tang W
Biosci Trends; 2013 Feb; 7(1):1-6. PubMed ID: 23524887
[TBL] [Abstract][Full Text] [Related]
2. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
Kee KM; Lu SN
Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
[TBL] [Abstract][Full Text] [Related]
3. Tight association of hepatocellular carcinoma with HBV infection in North China.
Gao JD; Shao YF; Xu Y; Ming LH; Wu ZY; Liu GT; Wang XH; Gao WH; Sun YT; Feng XL; Liang LM; Zhang YH; Sun ZT
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):46-9. PubMed ID: 15730918
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
5. Viral hepatitis and hepatocellular carcinoma.
Sallie R; Di Bisceglie AM
Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
[TBL] [Abstract][Full Text] [Related]
6. China's efforts to shed its title of "Leader in liver disease".
Li X; Xu WF
Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
8. Current status of liver diseases in Korea: hepatocellular carcinoma.
Song IH; Kim KS
Korean J Hepatol; 2009 Dec; 15 Suppl 6():S50-9. PubMed ID: 20037280
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus and the control of hepatocellular carcinoma.
Blumberg BS
IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic ultrasound and fine-needle aspiration for the diagnosis of hepatocellular carcinoma.
Maheshwari A; Kantsevoy S; Jagannath S; Thuluvath PJ
Clin Liver Dis; 2010 May; 14(2):325-32. PubMed ID: 20682238
[TBL] [Abstract][Full Text] [Related]
13. [Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].
Kim YJ; Lee HS
Korean J Hepatol; 2009 Mar; 15(1):7-14. PubMed ID: 19346781
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
15. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences.
Evans AA; Chen G; Ross EA; Shen FM; Lin WY; London WT
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):369-76. PubMed ID: 11927497
[TBL] [Abstract][Full Text] [Related]
16. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
17. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
[TBL] [Abstract][Full Text] [Related]
18. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
19. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
